Skip to main content
LEXICON PHARMACEUTICALS, INC. logo

LEXICON PHARMACEUTICALS, INC. — Investor Relations & Filings

Ticker · LXRX ISIN · US5288723027 US Manufacturing
Filings indexed 1,032 across all filing types
Latest filing 2025-05-12 Major Shareholding Noti…
Country US United States of America
Listing US LXRX

About LEXICON PHARMACEUTICALS, INC.

https://www.lexpharma.com/

Lexicon Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative medicines. The company utilizes a unique approach centered on gene science and genetics to identify and validate novel drug targets. Its mission is to pioneer precise treatments that transform the lives of patients with serious and chronic conditions. Lexicon's activities encompass the full spectrum of drug development, from initial research through to bringing approved therapies to market.

Recent filings

Filing Released Lang Actions
Major Shareholding Notification 2025
Major Shareholding Notification
2025-05-12 English
ARS
Annual Report FY 2024
2025-04-22 English
DEFA14A
Regulatory Filings
2025-04-22 English
DEF 14A
Proxy Solicitation & Information Statement
2025-04-22 English
8-K
Regulatory Filings
2025-03-28 English
PRE 14A
Regulatory Filings
2025-03-25 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.